Few publications exist concerning allogeneic hematopoietic cell transplant (alloHCT) outcomes in non-Japanese patients with HTLV-1-associated ATLL. We detail the patient and disease characteristics, transplant approach, and clinical outcomes in 17 patients with ATLL at our institution who underwent alloHCT. We report favorable outcomes, with 8/17 in ongoing remission, 2/17 with prolonged (>6 years) disease-free survival, and a low incidence of transplant-related mortality (2/17). These results validate the feasibility and efficacy of alloHCT in non-Japanese patients with ATLL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531547 | PMC |
| http://dx.doi.org/10.1080/10428194.2021.1897806 | DOI Listing |
Publication Analysis
Top Keywords
non-japanese patients
8
patients atll
8
outcomes
4
outcomes adult
4
adult t-cell
4
t-cell leukemia/lymphoma
4
leukemia/lymphoma allogeneic
4
allogeneic stem
4
stem cell
4
cell transplantation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!